Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
75pct
55d open
vs 6,526 other HR bills in the 114th — cohort avg 56d
21st Century Cures Act (Sec. 2) The NIH and Cures Innovation Fund is established and funds are appropriated: (1) for biomedical research, including high-risk, high-reward research and research conducted by early stage investigators; (2) to develop and implement a strategic plan for biomedical research; and (3) to carry out specified provisions of this Act. TITLE I--DISCOVERY Subtitle A--National Institutes of Health Funding (Sec. 1001) This bill amends the Public Health Service Act to reauthorize the National Institutes of Health (NIH) through FY2018. (Sec. 1002) The NIH must establish an Innovation Prizes Program to fund areas of biomedical science that could realize significant advancements or improve health outcomes. Subtitle B--National Institutes of Health Planning and Administration (Sec. 1022) Directors of national research institutes and national centers have five-year terms in office. (Sec. 1023) The NIH must reduce the administrative burdens of researchers funded by the NIH. (Sec. 1027) The support the National Center for Advancing Translational Sciences may provide to clinical trials is extended through a later clinical trial phase. (Sec. 1028) Each national research institute must conduct or support high-risk, high-reward research. Subtitle C--Supporting Young Emerging Scientists (Sec. 1041) A loan repayment program is established for health professionals engaging in research. The maximum awards of other loan repayment programs are increased. Subtitle D--Capstone Grant Program (Sec. 1061) Capstone Awards are established to support outstanding scientists in concluding research programs. Recipients cannot be principal investigators on subsequent NIH awards. Subtitle E--Promoting Pediatric Research through the National Institutes of Health (Sec. 1081) The Pediatric Research Initiative is revised to require establishment of a National Pediatric Research Network comprised of pediatric research consortia. (Sec. 1083) The NIH must convene a workshop on appropriate age groupings and age exclusions in human research and must publish the number of children included in NIH research. Subtitle F--Advancement of the National Institutes of Health Research and Data Access (Sec. 1101) The NIH must standardize data in the clinical trial registry data bank. Subtitle G--Facilitating Collaborative Research (Sec. 1121) The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on clinical trial data. (Sec. 1122) The Centers for Disease Control and Prevention (CDC) must expand surveillance of neurological diseases. (Sec. 1124) The Department of Health and Human Services (HHS) must revise health information privacy rules to allow: (1) use of protected information for research purposes to be treated as use for health care operations, (2) remote access to information by researchers, and (3) individuals to authorize future use of their information for research. Subtitle H--Council for 21st Century Cures (Sec. 1141) The Council for 21st Century Cures, a nonprofit corporation, is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive measures. TITLE II--DEVELOPMENT Subtitle A--Patient-Focused Drug Development (Sec. 2001) This bill amends the Federal Food, Drug, and Cosmetic Act to require the FDA to establish processes under which patient experience data may be considered in the risk-benefit assessment of a new drug. Subtitle B--Qualification and Use of Drug Development Tools (Sec. 2021) The FDA must establish a process to qualify drug development tools (methods, materials, or measures that aid drug development and regulatory review) as reliable for use in supporting approval or investigational use of a drug. (Sec. 2022) The sponsor of a drug for a serious condition may request that the FDA agree to an accelerated approval development plan. The plan must include the design of the drug study. Subtitle C--FDA Advancement of Precision Medicine (Sec. 2041) The FDA must define “precision” drugs and the evidence needed to support their use in a subset of patients. To expedite clinical development of precision drugs for the treatment of serious or rare conditions, the FDA may rely upon data previously submitted for a different approved drug or indication. Subtitle D--Modern Trial Design and Evidence Development (Sec. 2061) The FDA must issue guidance that addresses using alternative statistical methods in clinical trials and in the development and review of drugs. (Sec. 2062) To support approval of a drug for a new indication, the FDA must evaluate the use of evidence from clinical experience (in place of evidence from clinical trials) and establish a streamlined data review program. Subtitle E--Expediting Patient Access (Sec. 2082) Manufacturers and distributors of investigational drugs for serious conditions must publish their policies on expanded access (also known as “compassionate use”). Subtitle F--Facilitating Responsible Manufacturer Communications (Sec. 2101) The definition of, and requirements for, health care economic information that is provided to entities selecting drugs for coverage or reimbursement are revised. Subtitle G--Antibiotic Drug Development (Sec. 2121) At the request of the sponsor of an antibacterial or antifungal drug for treatment of a serious infection, the FDA may agree on a process for developing data to support approval of the drug for use in a limited population of patients. HHS must monitor the use of antibacterial and antifungal drugs and resistance to these drugs. (Sec. 2122) The FDA must identify and publish susceptibility test interpretive criteria for antimicrobial drugs. (These criteria characterize the drug resistance of microbes.) The FDA may allow marketing of devices that use these criteria without premarket approval. (Sec. 2123) This bill amends title XVIII (Medicare) of the Social Security Act (SSAct) to require the Centers for Medicare & Medicaid Services (CMS) to provide an additional payment to certain hospitals for providing certain new antimicrobial drugs (DISARM drugs) to inpatients. Total additional payments cannot exceed 0.02% of total payments to hospitals. Subtitle H--Vaccine Access, Certainty, and Innovation (Sec. 2141) The Advisory Committee on Immunization Practices must expedite review of certain vaccines. The CDC must provide a vaccine developer, upon request, with information on public health needs and priorities and certain epidemiological analyses or data. Subtitle I--Orphan Product Extensions Now; Incentives for Certain Products for Limited Populations (Sec. 2151) The marketing exclusivity period of a drug approved for a new indication that is a rare disease or condition is extended by six months. (Sec. 2152) The priority review voucher program for rare pediatric diseases is extended through 2018 and revised to apply only to serious diseases. Subtitle J--Domestic Manufacturing and Export Efficiencies (2162) This bill amends the Controlled Substances Import and Export Act to allow unimpeded re-exportation of certain exported controlled substances within the European Economic Area. Subtitle K--Enhancing Combination Products Review (Sec. 2181) The FDA must describe the responsibilities of each agency center charged with reviewing drugs, medical devices, or biological products when reviewing a product that is a combination of drug, medical device, or biological product. Subtitle L--Priority Review for Breakthrough Devices (Sec. 2201) The FDA must establish a program for priority review of breakthrough medical devices. Subtitle M--Medical Device Regulatory Process Improvements (Sec. 2221) The FDA must accredit third parties to certify device manufactures’ quality systems as meeting FDA criteria. The FDA must rely on this certification when determining the safety and effectiveness of certain changes to medical devices. (Sec. 2222) “Valid scientific evidence” is defined for purposes of the FDA determining the effectiveness of a medical device without clinical investigations. (Sec. 2223) FDA employees that review premarket submissions of medical devices must receive training regarding the “least burdensome appropriate means” concept. (Sec. 2225) The FDA must identify types of medical devices that do not require submission of a report prior to commercial marketing. (Sec. 2227) The FDA may exempt from effectiveness requirements certain medical devices intended to benefit fewer than 8,000 individuals. Subtitle N--Sensible Oversight for Technology Which Advances Regulatory Efficiency (Sec. 2241) “Health software” is defined and, with specified exceptions, exempted from FDA regulation. Subtitle O--Streamlining Clinical Trials (Sec. 2262) Institutional Review Boards responsible for reviewing plans for clinical testing of a medical device no longer need to be local. (Sec. 2263) Clinical testing of medical devices or drugs no longer requires the informed consent of the subjects if the testing poses no more than minimal risk and includes safeguards. Subtitle P--Improving Scientific Expertise and Outreach at FDA (Sec. 2281) The Silvio O. Conte Senior Biomedical Research Service is revised to remove the limit on the number of members and make other changes. (Sec. 2283) Changes are made to the Reagan-Udall Foundation for the Food and Drug Administration to revise Board of Directors membership, Executive Director compensation, and accounting. (Sec. 2285) The FDA is granted additional hiring authority for scientific, technical, or professional positions within certain centers. Subtitle Q--Exempting from Sequestration Certain User Fees (Sec. 2301) This bill amends the Balanced Budget and Emergency Deficit Control Act of 1985 to exempt from sequestration FDA administrative expenses funded through certain user fees. Subtitle R--Other Provisions (Sec. 2321) This bill expresses the sense of Congress that recording unique medical device identifiers in electronic health records could enhance medical surveillance. TITLE III--DELIVERY Subtitle A--Interoperability (Sec. 3001) Requirements are established for interoperability and certification of health information technology. Practices that discourage the exchange of electronic health information are prohibited. Subtitle B--Telehealth (Sec. 3021) The CMS and Medicare Payment Advisory Commission must provide information to Congress regarding telehealth. Subtitle C--Encouraging Continuing Medical Education for Physicians (Sec. 3041) Part A (General Provisions) of title XI of the SSAct is amended to remove the requirement that manufacturers of medical products report payments to physicians for certain educational activities. Subtitle D--Disposable Medical Technologies The CMS must pay home health agencies for certain disposable medical devices furnished to individuals receiving home health services under Medicare. Subtitle E--Local Coverage Decision Reforms (Sec. 3081) Medicare administrative contractors must publish local coverage determinations. Subtitle F--Medicare Pharmaceutical and Technology Ombudsman (Sec. 3101) A pharmaceutical and technology ombudsman within the CMS must receive and respond to complaints from manufacturers of medical products regarding Medicare coverage of their products. Subtitle G--Medicare Site-of-Service Price Transparency (Sec. 3121) The CMS must publish estimated Medicare beneficiary prices for items and services provided by hospital outpatient departments or ambulatory surgical centers. Subtitle H--Medicare Part D Patient Safety and Drug Abuse Prevention (Sec. 3141) Medicare prescription drug plan sponsors may limit the access of certain beneficiaries to frequently abused drugs. TITLE IV--MEDICAID, MEDICARE, AND OTHER REFORMS Subtitle A--Medicaid and Medicare Reforms (Sec. 4001) Aggregate Medicaid payments to states for durable medical equipment are limited to the amount that would be paid under Medicare, effective January 1, 2020. (Sec. 4002) Generic drugs authorized by the brand name drug manufacturer are excluded from the calculation of average manufacturer price when determining rebates under Medicaid. (Sec. 4003) Medicare payments are reduced for x-ray imaging that uses film or an imaging plate (instead of a digital sensor). After 2016, a multiple procedure payment reduction policy cannot be applied to a physician’s imaging services until the CMS publishes an analysis of any efficiencies that may exist when more than one study is performed on the same patient on the same day. (Sec. 4004) Medicare payments for infusion drugs and biologicals furnished through durable medical equipment are revised. (Sec. 4005) CMS must expand and extend through August 31, 2018, the Prior Authorization of Power Mobility Devices Demonstration. (Sec. 4006) For HHS grants, contracts, or other agreements, monetary penalties are established for fraudulent claims, fraudulent statements, and failure to provide timely access to the Inspector General of HHS. Subtitle B--Other Reforms (Sec. 4041) The Department of Energy must sell crude oil from the Strategic Petroleum Reserve. Subtitle C--Miscellaneous (Sec. 4061) HHS must: (1) conduct or support research on Lyme disease and other tick-borne diseases, (2) establish the Interagency Lyme and Tick-Borne Disease Working Group, and (3) submit a strategic plan for tick-borne disease research.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (431)
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Motion to reconsider laid on the table Agreed to without objection.
On passage Passed by recorded vote: 344 - 77 (Roll no. 433).
HousePassed/agreed to in House: On passage Passed by recorded vote: 344 - 77 (Roll no. 433).
HouseThe House adopted the amendments en gross as agreed to by the Committee of the Whole House on the state of the Union. (text of bill as amended: CR H5035-5069)
The previous question was ordered pursuant to the rule. (consideration: CR H5082)
The House rose from the Committee of the Whole House on the state of the Union to report H.R. 6.
UNFINISHED BUSINESS - The Chair announced that the unfinished business was the question on adoption of amendments which had been debated earlier and on which further proceedings had been postponed.
DEBATE - Pursuant to the provisions of H. Res. 350, the Committee of the Whole proceeded with 10 minutes of debate on the Jackson Lee amendment No. 8.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2020 · second_quarter · Computer Industry
Legislative & Regulatory Issues Related to Technology Policy, including R&D, Cybersecurity, Privacy, Health IT & Technology Procurement: Emerging technologies: Blockchain, cloud, AI, IOT, quantum computing; antitrust investigations of digital platforms; implementation of H.R. 6227, S. 3143, the National Quantum Initiative Act (P.L. 115-368); H.R. 1361, the Blockchain Promotion Act of 2019; S. 1558, the Artificial Intelligence Initiative Act (AI-IA); S. 847, the Commercial Facial Recognition Privacy Act of 2019, S. 2878, the Facial Recognition Technology Warrant Act of 2019, and S. 1363, the AI in Government Act of 2019; S. 3189, H.R. 6624 the USA Telecommunications Act; H.R. 6216, The National Artificial Intelligence Initiative Act; S. 3965, the Artificial Intelligence for the Armed Forces Act; H.R. 6978, the Endless Frontier Act; H.R. 7178, S. 3933, the Creating Helpful Incentives to Produce Semiconductors (CHIPS) for America Act; S. 1558, H.R. 7096, the National AI Research Resource Task Force Act; S. 4130, the American Foundries Act of 2020; S. 4066, the Platform Accountability and Consumer Transparency (PACT) Act; S. 2200, implementation of the National Integrated Drought Information System Reauthorization Act of 2018. Implementation of H.R. 6, 21st Century Cures Act. Chairman Wicker Staff Discussion Draft United States Consumer Data Privacy Act, S. 2968 Consumer Online Privacy Rights Act; S. 3398 Eliminating Abusive and Rampant Neglect of Interactive Technologies Act of 2020 (EARN IT Act); Supply chain security / DHS ICT Supply Chain Task Force; H.R. 4217 State and Local Cyber Improvement Act; HR 5823 State and Local Cyber Improvement Act; Implementation of H.R. 7327 the Strengthening and Enhancing Cyber-capabilities by Utilizing Risk Exposure Technology Act (SECURE Technology Act); S.2775 Harvesting American Cybersecurity Knowledge through Education Act of 2019 (HACKED Act); encryption policy; S. 3045 Cybersecurity Vulnerability Identification and Notification Act of 2019; guidance on Essential Critical infrastructure workforce; S. 3712 Cybersecurity Competitions to Yield Better Efforts to Research the Latest Exceptionally Advanced Problems Act of 2020 (CYBER LEAP Act); S. 734 Internet of Things Cybersecurity Improvement Act.
Client expense: $1,040,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Council of Economic Advisers (CEA), Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2020 · first_quarter · Computer Industry
Legislative & Regulatory Issues Related to Technology Policy, including R&D, Cybersecurity, Privacy, Health IT & Technology Procurement: Emerging technologies: Blockchain, cloud, Artificial Intelligence, Internet of Things, Quantum Computing; Implementation of H.R. 6227, S. 3143, the National Quantum Initiative Act (P.L. 115-368); H.R. 1361, the Blockchain Promotion Act of 2019; S. 1558, the Artificial Intelligence Initiative Act (AI-IA); S. 847, the Commercial Facial Recognition Privacy Act of 2019, S. 2878, the Facial Recognition Technology Warrant Act of 2019, and S. 1363, the AI in Government Act of 2019; 5G issues and strategy; S. 3189, USA Telecommunications Act; H.R. 6216, The National Artificial Intelligence Initiative Act. Implementation of H.R. 6, 21st Century Cures Act. Chairman Wicker Staff Discussion Draft United States Consumer Data Privacy Act, S. 2968 Consumer Online Privacy Rights Act; S. 3398 Eliminating Abusive and Rampant Neglect of Interactive Technologies Act of 2020 (EARN IT Act); DHS Information Communications Technology Supply Chain Task Force; H.R. 4217 State and Local Cyber Improvement Act; HR 5823 State and Local Cyber Improvement Act; Implementation of H.R. 7327 the Strengthening and Enhancing Cyber-capabilities by Utilizing Risk Exposure Technology Act (SECURE Technology Act); S.2775 Harvesting American Cybersecurity Knowledge through Education Act of 2019 (HACKED Act); Encryption policy; S. 3045 Cybersecurity Vulnerability Identification and Notification Act of 2019; Guidance on Essential Critical Infrastructure Workforce.
Client expense: $1,590,000 · Firm income: Not reported
2019 · fourth_quarter · Computer Industry
Legislative & Regulatory Issues Related to Technology Policy, including R&D, Cybersecurity, Privacy, Health IT & Technology Procurement: Emerging technologies: Blockchain, cloud, AI, IOT, Quantum Computing; Implementation of H.R. 6227, S. 3143, the National Quantum Initiative Act (P.L. 115-368); H.R. 1361, the Blockchain Promotion Act of 2019; Implementation of the Cloud Act (P.L. No. 115-141); S. 1558, the Artificial Intelligence Initiative Act (AI-IA); H.R. 2202, the Growing Artificial Intelligence Through Research (GrAITR) Act; S. 847, the Commercial Facial Recognition Privacy Act of 2019, S. 2878, the Facial Recognition Technology Warrant Act of 2019, and S. 1363, the AI in Government Act of 2019 Implementation of H.R. 6, 21st Century Cures Act; Implementation of H.R. 6, the SUPPORT Act; Cures 2.0 (no bill as yet) H.R. 1668, S. 734 Internet of Things Cybersecurity Improvement Act of 2019; Privacy Legislation, including H.R. 2013; Information Transparency and Personal Data Control Act; H.R. 4978 Online Privacy Act of 2019, and S. 2968 Consumer Online Privacy Rights Act; House, Senate S. 1457, Sharing Urgent, Potentially Problematic Locations that Yield Communications Hazards in American Internet Networks (SUPPLY CHAIN) Act; HR 1158, DHS Cyber Incident Response Teams Act of 2019; Implementation of SECURE Technology Act; Amendment of Section 230 of the Communications Decency Act of 1996; H.R. 4217 State and Local Cyber Improvement Act; Implementation of SECURE Technology Act; S 2775 Harvesting American Cybersecurity Knowledge through Education Act of 2019 (HACKED Act); Encryption policy
Client expense: $1,120,000 · Firm income: Not reported
2019 · fourth_quarter · Health Issues
S.692, Protect Medical Innovation Act of 2019; H.R.6, 21st Century Cures Act - Clinical Laboratory Improvement Act - waiver guidance implementation, regulation of point of care diagnostics products; Verifying Accurate Leading-Edge IVCT Development Act (discussion draft), modernizes regulations of in vitro diagnostics; S.734, Internet of Things Cybersecurity Improvement Act, creates national standards for cybersecurity for products purchased by the federal government; S.142, Data Dissemination Act - creates data privacy rules; S.189, Social Media Privacy Protection and Consumer Rights Act; Draft legislation to create new value base care arrangement safe harbors under Stark and Anti-Kickback Statutes and Educate key staff on FDA regulation of device service.
Client expense: $870,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2019 · second_quarter · Computer Industry
Legislative & Regulatory Issues Related to Technology Policy, including R&D, Cybersecurity, Privacy, Health IT & Technology Procurement: Emerging technologies: Blockchain, cloud, AI, IOT, Quantum Computing; Implementation of H.R. 6227, S. 3143, the National Quantum Initiative Act (P.L. 115-368); H.R. 1361, the Blockchain Promotion Act of 2019; H.R. 2144, the Token Taxonomy Act of 2019; Implementation of the Cloud Act (P.L. No. 115-141); S. 1558, the Artificial Intelligence Initiative Act (AI-IA); H.R. 2202, the Growing Artificial Intelligence Through Research (GrAITR) Act; S. 2200 National Integrated Drought Information System Reauthorization Act of 2018, related to weather prediction and cloud computing; Amendments to section 230 of the Communications Decency Act. Implementation of H.R. 6, 21st Century Cures Act; Implementation of H.R. 6, the SUPPORT Act; Price Transparency; S. 1895, the Lower Health Care Costs Act; Technology aspects of Medicare and Medicaid program fraud, waste, and abuse prevention. H.R. 1668, S. 734 Internet of Things Cybersecurity Improvement Act of 2019; Supply chain security; Data Security; H.R. 2013 Information Transparency and Personal Data Control Act; Privacy Legislation; S. 1457, Sharing Urgent, Potentially Problematic Locations that Yield Communications Hazards in American Internet Networks (SUPPLY CHAIN) Act; HR 1158, DHS Cyber Incident Response Teams Act of 2019; Implementation of SECURE Technology Act.
Client expense: $1,440,000 · Firm income: Not reported
DEBATE - Pursuant to the provisions of H. Res. 350, the Committee of the Whole proceeded with 10 minutes of debate on the Polis amendment No. 7.
DEBATE - Pursuant to the provisions of H. Res. 350, the Committee of the Whole proceeded with 10 minutes of debate on the Fitzpatrick amendment No. 6.
DEBATE - Pursuant to the provisions of H. Res. 350, the Committee of the Whole proceeded with 10 minutes of debate on the Slaughter amendment No. 5.
DEBATE - Pursuant to the provisions of H. Res. 350, the Committee of the Whole proceeded with 10 minutes of debate on the Castro (TX) amendment No. 4.
POSTPONED PROCEEDINGS - At the conclusion of debate on the Lee amendment, the Chair put the question on adoption of the amendment and by voice vote, announced that the ayes had prevailed. Ms. Lee demanded a recorded vote and the Chair postponed further proceedings on the question of adoption of the amendment until a time to be announced.
DEBATE - Pursuant to the provisions of H. Res. 350, the Committee of the Whole proceeded with 10 minutes of debate on the Lee amendment No. 3.
DEBATE - Pursuant to the provisions of H. Res. 350, the Committee of the Whole proceeded with 10 minutes of debate on the Young (IN) amendment No. 2.
POSTPONED PROCEEDINGS - At the conclusion of debate on the Brat amendment, the Chair put the question on adoption of the amendment and by voice vote, announced that the noes had prevailed. Mr. Brat demanded a recorded vote and the Chair postponed further proceedings on the question of adoption of the amendment until a time to be announced.
DEBATE - Pursuant to the provisions of H. Res. 350, the Committee of the Whole proceeded with 10 minutes of debate on the Brat amendment No. 1.
The House resolved into Committee of the Whole House on the state of the Union for further consideration.
Considered as unfinished business. (consideration: CR H5035-5082)
Committee of the Whole House on the state of the Union rises leaving H.R. 6 as unfinished business.
On motion that the Committee now rise. Agreed to by voice vote.
Mr. Upton moved that the Committee now rise.
GENERAL DEBATE - The Committee of the Whole proceeded with one hour of general debate on H.R. 6.
The Speaker designated the Honorable Cresent Hardy to act as Chairman of the Committee.
House resolved itself into the Committee of the Whole House on the state of the Union pursuant to H. Res. 350 and Rule XVIII.
Rule provides for consideration of H.R. 6 with 1 hour of general debate. Previous question shall be considered as ordered without intervening motions except motion to recommit with or without instructions. Measure will be considered read. Specified amendments are in order.
Considered under the provisions of rule H. Res. 350. (consideration: CR H5008-5016)
Rule H. Res. 350 passed House.
Rules Committee Resolution H. Res. 350 Reported to House. Rule provides for consideration of H.R. 6 with 1 hour of general debate. Previous question shall be considered as ordered without intervening motions except motion to recommit with or without instructions. Measure will be considered read. Specified amendments are in order.
Placed on the Union Calendar, Calendar No. 142.
Committee on Ways and Means discharged.
Committee on Ways and Means discharged.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-190, Part I.
Congress.gov source codes: 5000, H12200
Ordered to be Reported (Amended) by the Yeas and Nays: 51 - 0.
Committee Consideration and Mark-up Session Held.
Committee Consideration and Mark-up Session Held.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Congress.gov source codes: H11100, H11100-A
Introduced in House
Congress.gov source codes: 1000, Intro-H
| House |
| Markup by |
| May 21, 2015 |
| Ways and Means Committee | House | Referred to | May 19, 2015 |
| Energy and Commerce Committee | House | Referred to | May 19, 2015 |
| May 19, 2015 |
| Democratic |
| FL |
| Ami Bera | Democratic | CA |
| Ander Crenshaw | Republican | FL |
| Andy Harris | Republican | MD |
| Ann Kirkpatrick | Democratic | AZ |
| Ann M. Kuster | Democratic | NH |
| Ann Wagner | Republican | MO |
| Anna G. Eshoo | Democratic | CA |
| Barbara Comstock | Republican | VA |
| Barbara Lee | Democratic | CA |
| Ben Ray Luján | Democratic | NM |
| Beto O’Rourke | Democratic | TX |
| Betty McCollum | Democratic | MN |
| Bill Flores | Republican | TX |
| Bill Huizenga | Republican | MI |
| Bill Johnson | Republican | OH |
| Billy Long | Republican | MO |
| Blaine Luetkemeyer | Republican | MO |
| Bob Gibbs | Republican | OH |
| Bobby L. Rush | Democratic | IL |
| Brad Ashford | Democratic | NE |
| Brad R. Wenstrup | Republican | OH |
| Brenda L. Lawrence | Democratic | MI |
| Brendan F. Boyle | Democratic | PA |
| Brett Guthrie | Republican | KY |
| Brian Higgins | Democratic | NY |
| C. A. Dutch Ruppersberger | Democratic | MD |
| Candice S. Miller | Republican | MI |
| Carlos Curbelo | Republican | FL |
| Carolyn B. Maloney | Democratic | NY |
| Cathy McMorris Rodgers | Republican | WA |
| Chaka Fattah | Democratic | PA |
| Charles B. Rangel | Democratic | NY |
| Charles W. Dent | Republican | PA |
| Cheri Bustos | Democratic | IL |
| Chris Collins | Republican | NY |
| Chris Van Hollen | Democratic | MD |
| Christopher P. Gibson | Republican | NY |
| Corrine Brown | Democratic | FL |
| Cresent Hardy | Republican | NV |
| Dan Benishek | Republican | MI |
| Daniel Lipinski | Democratic | IL |
| Daniel M. Donovan, Jr. | Republican | NY |
| Daniel T. Kildee | Democratic | MI |
| Daniel Webster | Republican | FL |
| David A. Trott | Republican | MI |
| David B. McKinley | Republican | WV |
| David G. Valadao | Republican | CA |
| David Loebsack | Democratic | IA |
| David N. Cicilline | Democratic | RI |
| David P. Joyce | Republican | OH |
| David P. Roe | Republican | TN |
| David Scott | Democratic | GA |
| David Young | Republican | IA |
| Debbie Dingell | Democratic | MI |
| Debbie Wasserman Schultz | Democratic | FL |
| Dennis A. Ross | Republican | FL |
| Denny Heck | Democratic | WA |
| Derek Kilmer | Democratic | WA |
| Diana DeGette | Democratic | CO |
| Donald M. Payne, Jr. | Democratic | NJ |
| Donna F. Edwards | Democratic | MD |
| Doris O. Matsui | Democratic | CA |
| Doug Collins | Republican | GA |
| Doug LaMalfa | Republican | CA |
| Duncan Hunter | Republican | CA |
| E. Scott Rigell | Republican | VA |
| Ed Perlmutter | Democratic | CO |
| Ed Whitfield | Republican | KY |
| Eddie Bernice Johnson | Democratic | TX |
| Edward R. Royce | Republican | CA |
| Eleanor Holmes Norton | Democratic | DC |
| Eliot L. Engel | Democratic | NY |
| Elise M. Stefanik | Republican | NY |
| Emanuel Cleaver | Democratic | MO |
| Erik Paulsen | Republican | MN |
| Evan H. Jenkins | Republican | WV |
| Frank A. LoBiondo | Republican | NJ |
| Frank C. Guinta | Republican | NH |
| Frank Pallone, Jr. | Democratic | NJ |
| Frederica S. Wilson | Democratic | FL |
| G. K. Butterfield | Democratic | NC |
| Gene Green | Democratic | TX |
| Grace Meng | Democratic | NY |
| Greg Walden | Republican | OR |
| Gregg Harper | Republican | MS |
| Gus M. Bilirakis | Republican | FL |
| Gwen Moore | Democratic | WI |
| H. Morgan Griffith | Republican | VA |
| Henry C. "Hank" Johnson, Jr. | Democratic | GA |
| Ileana Ros-Lehtinen | Republican | FL |
| Jackie Speier | Democratic | CA |
| Jackie Walorski | Republican | IN |
| Jaime Herrera Beutler | Republican | WA |
| James P. McGovern | Democratic | MA |
| James R. Langevin | Democratic | RI |
| Janice D. Schakowsky | Democratic | IL |
| Janice Hahn | Democratic | CA |
| Jared Huffman | Democratic | CA |
| Jared Polis | Democratic | CO |
| Jeff Denham | Republican | CA |
| Jeff Fortenberry | Republican | NE |
| Jerrold Nadler | Democratic | NY |
| Jerry McNerney | Democratic | CA |
| Jim Costa | Democratic | CA |
| Joaquin Castro | Democratic | TX |
| Joe Barton | Republican | TX |
| Joe Courtney | Democratic | CT |
| John A. Yarmuth | Democratic | KY |
| John B. Larson | Democratic | CT |
| John Garamendi | Democratic | CA |
| John K. Delaney | Democratic | MD |
| John Katko | Republican | NY |
| John Lewis | Democratic | GA |
| John P. Sarbanes | Democratic | MD |
| John R. Moolenaar | Republican | MI |
| John Shimkus | Republican | IL |
| Joseph J. Heck | Republican | NV |
| Joseph P. Kennedy III | Democratic | MA |
| Joseph R. Pitts | Republican | PA |
| Juan Vargas | Democratic | CA |
| Judy Chu | Democratic | CA |
| Julia Brownley | Democratic | CA |
| K. Michael Conaway | Republican | TX |
| Katherine M. Clark | Democratic | MA |
| Kathleen M. Rice | Democratic | NY |
| Kathy Castor | Democratic | FL |
| Keith Ellison | Democratic | MN |
| Ken Calvert | Republican | CA |
| Kenny Marchant | Republican | TX |
| Kevin Cramer | Republican | ND |
| Kevin Yoder | Republican | KS |
| Kurt Schrader | Democratic | OR |
| Kyrsten Sinema | Independent | AZ |
| Larry Bucshon | Republican | IN |
| Lee M. Zeldin | Republican | NY |
| Leonard Lance | Republican | NJ |
| Lois Capps | Democratic | CA |
| Lois Frankel | Democratic | FL |
| Lou Barletta | Republican | PA |
| Lucille Roybal-Allard | Democratic | CA |
| Luis V. Gutiérrez | Democratic | IL |
| Luke Messer | Republican | IN |
| Madeleine Z. Bordallo | Democratic | GU |
| Marc A. Veasey | Democratic | TX |
| Marcia L. Fudge | Democratic | OH |
| Marcy Kaptur | Democratic | OH |
| Mario Diaz-Balart | Republican | FL |
| Mark DeSaulnier | Democratic | CA |
| Mark Meadows | Republican | NC |
| Mark Pocan | Democratic | WI |
| Mark Takai | Democratic | HI |
| Mark Takano | Democratic | CA |
| Markwayne Mullin | Republican | OK |
| Marsha Blackburn | Republican | TN |
| Matt Cartwright | Democratic | PA |
| Matt Salmon | Republican | AZ |
| Maxine Waters | Democratic | CA |
| Michael C. Burgess | Republican | TX |
| Michael E. Capuano | Democratic | MA |
| Michael F. Doyle | Democratic | PA |
| Michael K. Simpson | Republican | ID |
| Michael R. Turner | Republican | OH |
| Michael T. McCaul | Republican | TX |
| Mike Bishop | Republican | MI |
| Mike Bost | Republican | IL |
| Mike Coffman | Republican | CO |
| Mike Pompeo | Republican | KS |
| Mike Quigley | Democratic | IL |
| Mike Rogers | Republican | AL |
| Mimi Walters | Republican | CA |
| Norma J. Torres | Democratic | CA |
| Nydia M. Velázquez | Democratic | NY |
| Patrick J. Tiberi | Republican | OH |
| Patrick T. McHenry | Republican | NC |
| Paul Cook | Republican | CA |
| Paul Tonko | Democratic | NY |
| Pedro R. Pierluisi | Democratic | PR |
| Pete Olson | Republican | TX |
| Peter J. Roskam | Republican | IL |
| Peter Welch | Democratic | VT |
| Randy Hultgren | Republican | IL |
| Renee L. Ellmers | Republican | NC |
| Richard Hudson | Republican | NC |
| Richard L. Hanna | Republican | NY |
| Richard M. Nolan | Democratic | MN |
| Rick W. Allen | Republican | GA |
| Robert A. Brady | Democratic | PA |
| Robert E. Latta | Republican | OH |
| Robert J. Dold | Republican | IL |
| Robert Pittenger | Republican | NC |
| Robin L. Kelly | Democratic | IL |
| Rodney Davis | Republican | IL |
| Ron Kind | Democratic | WI |
| Rubén Hinojosa | Democratic | TX |
| Ryan A. Costello | Republican | PA |
| Ryan K. Zinke | Republican | MT |
| Sam Farr | Democratic | CA |
| Scott DesJarlais | Republican | TN |
| Scott H. Peters | Democratic | CA |
| Scott Perry | Republican | PA |
| Seth Moulton | Democratic | MA |
| Sheila Jackson Lee | Democratic | TX |
| Steny H. Hoyer | Democratic | MD |
| Stephen Knight | Republican | CA |
| Steve Chabot | Republican | OH |
| Steve Cohen | Democratic | TN |
| Steve Israel | Democratic | NY |
| Steve Scalise | Republican | LA |
| Steve Stivers | Republican | OH |
| Steve Womack | Republican | AR |
| Susan A. Davis | Democratic | CA |
| Susan W. Brooks | Republican | IN |
| Suzan K. DelBene | Democratic | WA |
| Suzanne Bonamici | Democratic | OR |
| Tammy Duckworth | Democratic | IL |
| Ted Lieu | Democratic | CA |
| Tim Murphy | Republican | PA |
| Tim Ryan | Democratic | OH |
| Tim Walberg | Republican | MI |
| Timothy J. Walz | Democratic | MN |
| Tom Marino | Republican | PA |
| Tom Reed | Republican | NY |
| Tony Cárdenas | Democratic | CA |
| William R. Keating | Democratic | MA |
| Yvette D. Clarke | Democratic | NY |
| Zoe Lofgren | Democratic | CA |
| S 2188 |
114th |
| Related bill |
| S 2187 | 114th | Related bill |
| S 1913 | 114th | Related bill |
| S 1421 | 114th | Related bill |
| HRES 350 | 114th | Procedurally-related |
| HR 789 | 114th | Related bill |
| HR 34 | 114th | Related bill |
| HR 292 | 114th | Related bill |
| HR 2629 | 114th | Related bill |
| HR 2549 | 114th | Related bill |
| HR 2548 | 114th | Related bill |
| HR 2547 | 114th | Related bill |
| HR 2456 | 114th | Related bill |
| HR 2455 | 114th | Related bill |
| HR 2452 | 114th | Related bill |
| HR 2448 | 114th | Related bill |
| HR 2445 | 114th | Related bill |
| HR 2443 | 114th | Related bill |
| HR 2440 | 114th | Related bill |
| HR 2439 | 114th | Related bill |
| HR 2438 | 114th | Related bill |
| HR 2436 | 114th | Related bill |
| HR 2435 | 114th | Related bill |
| HR 2433 | 114th | Related bill |
| HR 2428 | 114th | Related bill |
| HR 2427 | 114th | Related bill |
| HR 2426 | 114th | Related bill |
| HR 2425 | 114th | Related bill |
| HR 2424 | 114th | Related bill |
| HR 2423 | 114th | Related bill |
| HR 2422 | 114th | Related bill |
| HR 2421 | 114th | Related bill |
| HR 2420 | 114th | Related bill |
| HR 2419 | 114th | Related bill |
| HR 2415 | 114th | Related bill |
| HR 2414 | 114th | Related bill |
| HR 2396 | 114th | Related bill |
| HR 2340 | 114th | Related bill |
| HR 2338 | 114th | Related bill |
| HR 2337 | 114th | Related bill |
| HR 2299 | 114th | Related bill |
| HR 2298 | 114th | Related bill |
| HCONRES 46 | 114th | Related bill |
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Employment & Training Administration, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, Treasury, Dept of, U.S. Trade & Development Agency (USTDA), U.S. Trade Representative (USTR), White House Office
Government targets: Commerce, Dept of (DOC), Consumer Financial Protection Bureau (CFPB), Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Security Council (NSC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2019 · third_quarter · Computer Industry
Legislative & Regulatory Issues Related to Technology Policy, including R&D, Cybersecurity, Privacy, Health IT & Technology Procurement: Emerging technologies: Blockchain, cloud, AI, IOT, Quantum Computing; Implementation of H.R. 6227, S. 3143, the National Quantum Initiative Act (P.L. 115-368); H.R. 1361, the Blockchain Promotion Act of 2019; H.R. 2144, the Token Taxonomy Act of 2019; Implementation of the Cloud Act (P.L. No. 115-141); S. 1558, the Artificial Intelligence Initiative Act (AI-IA); H.R. 2202, the Growing Artificial Intelligence Through Research (GrAITR) Act; S. 2200 National Integrated Drought Information System Reauthorization Act of 2018, related to weather prediction and cloud computing. Implementation of H.R. 6, 21st Century Cures Act; Implementation of H.R. 6, the SUPPORT Act. H.R. 1668, S. 734 Internet of Things Cybersecurity Improvement Act of 2019; Supply chain security; Data Security; H.R. 2013 Information Transparency and Personal Data Control Act; Privacy Legislation; S. 1457, Sharing Urgent, Potentially Problematic Locations that Yield Communications Hazards in American Internet Networks (SUPPLY CHAIN) Act; HR 1158, DHS Cyber Incident Response Teams Act of 2019; Implementation of SECURE Technology Act; Amendment of Section 230 of the Communications Decency Act of 1996; H.R. 4217 State and Local Cyber Improvement Act; Implementation of SECURE Technology Act; Internet of Things issues.
Client expense: $1,140,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Education, Dept of, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2019 · third_quarter · Health Issues
S.692, Protect Medical Innovation Act of 2019; H.R.6, 21st Century Cures Act - Clinical Laboratory Improvement Act - waiver guidance implementation, regulation of point of care diagnostics products; Verifying Accurate Leading-Edge IVCT Development Act (discussion draft), modernizes regulations of in vitro diagnostics; S.734, Internet of Things Cybersecurity Improvement Act, creates national standards for cybersecurity for products purchased by the federal government; S.142, Data Dissemination Act - creates data privacy rules; S.189, Social Media Privacy Protection and Consumer Rights Act; Draft legislation to create new value base care arrangement safe harbors under Stark and Anti-Kickback Statutes and Educate key staff on FDA regulation of device service.
Client expense: $870,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2019 · second_quarter · Computer Industry
Legislative & Regulatory Issues Related to Technology Policy, including R&D, Cybersecurity, Privacy, Health IT & Technology Procurement: Emerging technologies: Blockchain, cloud, AI, IOT, Quantum Computing; Implementation of H.R. 6227, S. 3143, the National Quantum Initiative Act (P.L. 115-368); H.R. 1361, the Blockchain Promotion Act of 2019; H.R. 2144, the Token Taxonomy Act of 2019; Implementation of the Cloud Act (P.L. No. 115-141); S. 1558, the Artificial Intelligence Initiative Act (AI-IA); H.R. 2202, the Growing Artificial Intelligence Through Research (GrAITR) Act; S. 2200 National Integrated Drought Information System Reauthorization Act of 2018, related to weather prediction and cloud computing; Amendments to section 230 of the Communications Decency Act. Implementation of H.R. 6, 21st Century Cures Act; Implementation of H.R. 6, the SUPPORT Act; Price Transparency; S. 1895, the Lower Health Care Costs Act; Technology aspects of Medicare and Medicaid program fraud, waste, and abuse prevention. H.R. 1668, S. 734 Internet of Things Cybersecurity Improvement Act of 2019; Supply chain security; Data Security; H.R. 2013 Information Transparency and Personal Data Control Act; Privacy Legislation; S. 1457, Sharing Urgent, Potentially Problematic Locations that Yield Communications Hazards in American Internet Networks (SUPPLY CHAIN) Act; HR 1158, DHS Cyber Incident Response Teams Act of 2019; Implementation of SECURE Technology Act.
Client expense: $1,600,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2019 · second_quarter · Health Issues
FDA report on regulation of non-manufacturer medical device service; H.R.307, Pandemic and All-Hazards Preparedness Act Reauthorization - stockpile and diagnostic products; Opioid Crisis Response Act of 2018, Discussion Draft - opioid testing and treatment; H.R.2207 and S.692, Protect Medical Innovation Act of 2019; H.R.6, 21st Century Cures Act - Clinical Laboratory Improvement Act - waiver guidance implementation, regulation of point of care diagnostics products; Diagnostic Accuracy and Innovation Act (Bucshon-DeGette) Discussion draft In vitro diagnostic regulatory reform; Verifying Accurate Leading-Edge IVCT Development Act (discussion draft), modernizes regulations of in vitro diagnostics; S.734, Internet of Things Cybersecurity Improvement Act, creates national standards for cybersecurity for products purchased by the federal government; S.142, Data Dissemination Act - creates data privacy rules; S.189, Social Media Privacy Protection and Consumer Rights Act; Draft legislation to create new value base care arrangement safe harbors under Stark and Anti-Kickback Statutes and Educate key staff on FDA regulation of device service.
Client expense: $1,170,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2019 · first_quarter · Computer Industry
Legislative & Regulatory Issues Related to Technology Policy, including R&D, Cybersecurity, Privacy, Health IT & Technology Procurement: Emerging technologies: Blockchain, cloud, AI, IOT, Quantum Computing; Implementation of H.R. 6227, S. 3143, the National Quantum Initiative Act (P.L. 115-368); H.R. 1361, the Blockchain Promotion Act of 2019; H.R. 2144, the Token Taxonomy Act of 2019; Implementation of the Cloud Act (P.L. No. 115-141). Implementation of H.R. 6, 21st Century Cures Act; Implementation of H.R. 6, the SUPPORT Act; Price Transparency. H.R. 1668, S. 734 Internet of Things Cybersecurity Improvement Act of 2019; Supply chain security; Data Security; H.R. 2013 Information Transparency and Personal Data Control Act; Privacy Legislation.
Client expense: $1,960,000 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2019 · first_quarter · Health Issues
FDA report on regulation of non-manufacturer medical device service; H.R.307, Pandemic and All-Hazards Preparedness Act Reauthorization - stockpile and diagnostic products; Opioid Crisis Response Act of 2018, Discussion Draft - opioid testing and treatment; H.R.2207 and S.692, Protect Medical Innovation Act of 2019; H.R.6, 21st Century Cures Act - Clinical Laboratory Improvement Act - waiver guidance implementation, regulation of point of care diagnostics products; Diagnostic Accuracy and Innovation Act (Bucshon-DeGette) Discussion draft In vitro diagnostic regulatory reform; Verifying Accurate Leading-Edge IVCT Development Act (discussion draft), modernizes regulations of in vitro diagnostics; S.734 - Internet of Things Cybersecurity Improvement Act, creates national standards for cybersecurity for products purchased by the federal government; S. 142, Data Dissemination Act - creates data privacy rules; S. 189, Social Media Privacy Protection and Consumer Rights Act.
Client expense: $1,140,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2019 · first_quarter · Medicare/Medicaid
Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, vents, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration; Ensuring Access to Quality Complex Rehabilitation Technology Act; Legislation to amend title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative wheelchairs and accessories; Issues related to reimbursement cuts in noncompetitive bidding areas, all provisions; 21st Century Cures Act (H.R. 6/H.R. 34 in the 114th Congress), competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; issues pertaining to the Interim Final Rule (IFR) regarding non CB Area Relief for DME Items; Expanding and making permanent the Medicare power mobility device demonstration program; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act, all provisions (S. 2368 in the 114th Congress); DME issues in the FY2020 President's Budget and CMS ESRD/DEMPOS proposed and final rules.
Client expense: Not reported · Firm income: $45,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · first_quarter · Medicare/Medicaid
Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, vents, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration; Ensuring Access to Quality Complex Rehabilitation Technology Act; Legislation to amend title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative wheelchairs and accessories; Issues related to reimbursement cuts in noncompetitive bidding areas, all provisions; 21st Century Cures Act (H.R. 6/H.R. 34 in the 114th Congress), competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; Issues pertaining to the Interim Final Rule (IFR) regarding non CB Area Relief for DME Items; Expanding and making permanent the Medicare power mobility device demonstration program; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act, all provisions (S. 2368 in the 114th Congress); DME issues in the FY2020 President's Budget and CMS ESRD/DEMPOS proposed and final rules.
Client expense: $200,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2018 · second_quarter · Computer Industry
Legislative & Regulatory Issues Related to Technology Policy, including R&D, Cybersecurity, Privacy, Health IT & Technology Procurement: Emerging technologies: Blockchain Technology, cloud, AI, IOT, Quantum Computing; S. 2217, the FUTURE of Artificial Intelligence Act of 2017; S. 760 Open, Public, Electronic, and Necessary Government Data Act; H.R. 6227, National Quantum Initiative Act. Implementation of H.R. 6, 21st Century Cures Act; S. 1693 Stop Enabling Sex Traffickers Act of 2017; H.R. 1865 Allow States and Victims to Fight Online Sex Trafficking Act of 2017. HR5674/S.2372 - VA Mission Act. Draft Data Acquisition and Technology Accountability and Security Act; S. 1989 Honest Ads Act, S.2382/H.R. 4943 Clarifying Use of Data (CLOUD) Act; cybersecurity vulnerability disclosure policy. S. 1691 Internet of Things Cybersecurity Improvement Act of 2017; data privacy; data breach, data security.
Client expense: $2,078,000 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Employment & Training Administration, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Immigration & Customs Enforcement (ICE), U.S. Trade Representative (USTR), White House Office
2018 · third_quarter · Health Issues
H.R. 5776 MOST Act. H.R. 6 21st Century CURES Act. Proposals to advance policies related to effective pain management. Issues related to medical device cybersecurity.
Client expense: $730,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
2018 · first_quarter · Health Issues
H.R. 6 21st Century CURES Act, Sec. 2228. Proposals to advance policies related to effective pain management. Issues related to medical device cybersecurity. Issues related to the implementation of the FDA Device Accountability Act of 2016.
Client expense: $820,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
2018 · second_quarter · Computer Industry
Legislative & Regulatory Issues Related to Technology Policy, including R&D, Cybersecurity, Privacy, Health IT & Technology Procurement: Emerging technologies: Blockchain Technology, cloud, AI, IOT, Quantum Computing; S. 2217, the FUTURE of Artificial Intelligence Act of 2017; S. 760 Open, Public, Electronic, and Necessary Government Data Act; H.R. 6227, National Quantum Initiative Act. Implementation of H.R. 6, 21st Century Cures Act; S. 1693 Stop Enabling Sex Traffickers Act of 2017; H.R. 1865 Allow States and Victims to Fight Online Sex Trafficking Act of 2017. HR5674/S.2372 - VA Mission Act. Draft Data Acquisition and Technology Accountability and Security Act; S. 1989 Honest Ads Act, S.2382/H.R. 4943 Clarifying Use of Data (CLOUD) Act; cybersecurity vulnerability disclosure policy. S. 1691 Internet of Things Cybersecurity Improvement Act of 2017; data privacy; data breach, data security.
Client expense: $1,620,000 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Employment & Training Administration, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Immigration & Customs Enforcement (ICE), U.S. Trade Representative (USTR), White House Office
2018 · fourth_quarter · Computer Industry
Legislative & Regulatory Issues Related to Technology Policy, including R&D, Cybersecurity, Privacy, Health IT & Technology Procurement: Emerging technologies: Blockchain Technology, cloud, AI, IOT, Quantum Computing; S. 2217, the FUTURE of Artificial Intelligence Act of 2017; H.R. 6227, S. 3143, the National Quantum Initiative Act; H.R. 6550 FedRAMP Reform Act of 2018; H Res. 1108 Sense of Congress on Blockchain; S. 3085 Federal Acquisition Supply Chain Security Act of 2018; Implementation of H.R. 6, 21st Century Cures Act; H.R. 7283, S. 1691 Internet of Things Cybersecurity Improvement Act of 2017; draft data privacy framework legislation; data breach; data security.
Client expense: $840,000 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Equal Employment Opportunity Commission (EEOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Intl Trade Administration (ITA), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2018 · fourth_quarter · Health Issues
H.R. 2646, the Helping Families in Mental Health Crisis Act; H.R. 2690, Strengthening Mental Health In Our Communities Act; H.R. 6, 21st Century Cures initiative; S. 481, Improving Regulatory Transparency for New Medical Therapies Act
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Health Issues
FDA report on regulation of non-manufacturer medical device service; H.R.307, Pandemic and All-Hazards Preparedness Act Reauthorization - stockpile and diagnostic products; Opioid Crisis Response Act of 2018, Discussion Draft - opioid testing and treatment; H.R.6, 21st Century Cures Act - Clinical Laboratory Improvement Act - waiver guidance implementation, regulation of point of care diagnostics products; Diagnostic Accuracy and Innovation Act (Bucshon-DeGette) Discussion draft In vitro diagnostic regulatory reform.
Client expense: $1,020,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Council on Environmental Quality (CEQ), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2018 · fourth_quarter · Medicare/Medicaid
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479 and regulatory issues related to the Medicare coinsurance issue in these bills; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015. H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, respecting Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, and protecting communities. Draft legislation on establishment of Medicaid payment for patient navigation. Issues relating to Medicaid covering routine care costs for beneficiaries who participate in an approved clinical trial. Issues related to Medicare coverage for BCRA testing and preventive surgery (proposed Murkowski legislation).
Client expense: $1,610,710 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
2018 · fourth_quarter · Health Issues
Concerns with upper payment limits contained in H.R. 6- 21st Century Cures Act, 114th Congress, and the accelerated implementation date. Also working on clear definition of what items are covered by the 21st century Cures Act. Additional concerns with CMS potentially adding ventilators to the competitive bid program.
Client expense: Not reported · Firm income: $10,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Medicare/Medicaid
Concerns with upper payment limit contained in H.R. 6- 21st Century Cures Act, 114th Congress, and the accelerated implementation date. Also working on a clear definition of what is included under 21st Century Cures Act.Additional concerns with CMS potentially adding ventilators to the competitive program.
Client expense: Not reported · Firm income: $10,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Computer Industry
Legislative & Regulatory Issues Related to Technology Policy, including R&D, Cybersecurity, Privacy, Health IT & Technology Procurement: Emerging technologies: Blockchain Technology, cloud, AI, IOT, Quantum Computing; S. 2217, the FUTURE of Artificial Intelligence Act of 2017; S. 760 Open, Public, Electronic, and Necessary Government Data Act; H.R. 6227, National Quantum Initiative Act. Implementation of H.R. 6, 21st Century Cures Act; S. 1693 Stop Enabling Sex Traffickers Act of 2017; H.R. 1865 Allow States and Victims to Fight Online Sex Trafficking Act of 2017. HR5674/S.2372 - VA Mission Act. Draft Data Acquisition and Technology Accountability and Security Act; S. 1989 Honest Ads Act, S.2382/H.R. 4943 Clarifying Use of Data (CLOUD) Act; cybersecurity vulnerability disclosure policy. S. 1691 Internet of Things Cybersecurity Improvement Act of 2017; data privacy; data breach, data security.
Client expense: $1,620,000 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Employment & Training Administration, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Immigration & Customs Enforcement (ICE), U.S. Trade Representative (USTR), White House Office
2018 · fourth_quarter · Computer Industry
Legislative & Regulatory Issues Related to Technology Policy, including R&D, Cybersecurity, Privacy, Health IT & Technology Procurement: Emerging technologies: Blockchain Technology, cloud, AI, IOT, Quantum Computing; S. 2217, the FUTURE of Artificial Intelligence Act of 2017; H.R. 6227, S. 3143, the National Quantum Initiative Act; H.R. 6550 FedRAMP Reform Act of 2018; H Res. 1108 Sense of Congress on Blockchain; S. 3085 Federal Acquisition Supply Chain Security Act of 2018; Implementation of H.R. 6, 21st Century Cures Act; H.R. 7283, S. 1691 Internet of Things Cybersecurity Improvement Act of 2017; draft data privacy framework legislation; data breach; data security.
Client expense: $830,000 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Equal Employment Opportunity Commission (EEOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Intl Trade Administration (ITA), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2018 · fourth_quarter · Medicare/Medicaid
- Home Infusion technical change to H.R.6 21st Century Cures to move wrap around training and monitoring services benefit forward from 2021 to 2018 implementation. - Medicare coverage and reimbursement - Medicare Part B drug payment model demonstration - HR 4724: Medicare IVIG Access Enhancement Act - Medicare Part D
Client expense: $230,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Medicare/Medicaid
Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration; H.R. 750 - Ensuring Access to Quality Complex Rehabilitation Technology Act; H.R. 1361/S. 486/H.R. 3730 - To amend title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative wheelchairs and accessories (Protecting Beneficiary Access to Complex Rehab Technology Act of 2017); The IMPROVE Act; H.R. 7217; Issues related to reimbursement cuts in noncompetitive bidding areas, all provisions; 21st Century Cures Act (H.R. 6/H.R. 34 in the 114th Congress), competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2445 - the DMEPOS Access and Transparency Act of 2017 (DATA Act), all provisions; H.R. 4229 - Protecting HOME Access Act of 2017, all provisions; H.R. 2550 - Medicare Telehealth Parity Act of 2017, all provisions; H.R. 1625 - Consolidated Appropriations Act of 2018; issues pertaining to the Interim Final Rule (IFR) regarding non CB Area Relief for DME Items; Expanding and making permanent the Medicare power mobility device demonstration program; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act, all provisions (S. 2368 in the 114th Congress); DME issues in the FY2019 President's Budget and CMS ESRD/DEMPOS proposed and final rules.
Client expense: Not reported · Firm income: $45,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
2018 · fourth_quarter · Medicare/Medicaid
Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration; H.R. 750 - Ensuring Access to Quality Complex Rehabilitation Technology Act; H.R. 1361/S. 486/H.R. 3730 - To amend title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative wheelchairs and accessories (Protecting Beneficiary Access to Complex Rehab Technology Act of 2017); H.R. 7217 - The IMPROVE Act, all provisions; Issues related to reimbursement cuts in noncompetitive bidding areas, all provisions; 21st Century Cures Act (H.R. 6/H.R. 34 in the 114th Congress), competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2445 - the DMEPOS Access and Transparency Act of 2017 (DATA Act), all provisions; H.R. 4229 - Protecting HOME Access Act of 2017, all provisions; H.R. 2550 - Medicare Telehealth Parity Act of 2017, all provisions; H.R. 1625 - Consolidated Appropriations Act of 2018; issues pertaining to the Interim Final Rule (IFR) regarding non CB Area Relief for DME Items; Expanding and making permanent the Medicare power mobility device demonstration program; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act, all provisions (S. 2368 in the 114th Congress); DME issues in the FY2019 President's Budget and CMS ESRD/DEMPOS proposed and final rules.
Client expense: $170,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2018 · third_quarter · Health Issues
H.R. 2646, the Helping Families in Mental Health Crisis Act; H.R. 2690, Strengthening Mental Health In Our Communities Act; H.R. 6, 21st Century Cures initiative; S. 481, Improving Regulatory Transparency for New Medical Therapies Act
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Computer Industry
Legislative & Regulatory Issues Related to Technology Policy, including R&D, Cybersecurity, Privacy, Health IT & Technology Procurement: Emerging technologies: Blockchain Technology, cloud, AI, IOT, Quantum Computing; S. 2217, the FUTURE of Artificial Intelligence Act of 2017; S. 760 Open, Public, Electronic, and Necessary Government Data Act; H.R. 6227, National Quantum Initiative Act. Implementation of H.R. 6, 21st Century Cures Act; S. 1693 Stop Enabling Sex Traffickers Act of 2017; H.R. 1865 Allow States and Victims to Fight Online Sex Trafficking Act of 2017. HR5674/S.2372 - VA Mission Act. Draft Data Acquisition and Technology Accountability and Security Act; S. 1989 Honest Ads Act, S.2382/H.R. 4943 Clarifying Use of Data (CLOUD) Act; cybersecurity vulnerability disclosure policy. S. 1691 Internet of Things Cybersecurity Improvement Act of 2017; data privacy; data breach, data security.
Client expense: $1,600,000 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Employment & Training Administration, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Immigration & Customs Enforcement (ICE), U.S. Trade Representative (USTR), White House Office
2018 · third_quarter · Computer Industry
Legislative & Regulatory Issues Related to Technology Policy, including R&D, Cybersecurity, Privacy, Health IT & Technology Procurement: Emerging technologies: Blockchain Technology, cloud, AI, IOT, Quantum Computing; S. 2217, the FUTURE of Artificial Intelligence Act of 2017; H.R. 6227, S. 3143, the National Quantum Initiative Act; H.R. 6550 FedRAMP Reform Act of 2018; H Res. 1108 Sense of Congress on Blockchain; Implementation of H.R. 6, 21st Century Cures Act. S. 1691 Internet of Things Cybersecurity Improvement Act of 2017; data breach; data security; vulnerability disclosure policy. Draft data privacy framework legislation.
Client expense: $900,000 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Telecommunications & Information Administration (NTIA), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2018 · third_quarter · Health Issues
FDA report on regulation of non-manufacturer medical device service; H.R.307, Pandemic and All-Hazards Preparedness Act Reauthorization - stockpile and diagnostic products; Opioid Crisis Response Act of 2018, Discussion Draft - opioid testing and treatment; H.R.6, 21st Century Cures Act - Clinical Laboratory Improvement Act - waiver guidance implementation, regulation of point of care diagnostics products; Diagnostic Accuracy and Innovation Act (Bucshon-DeGette) Discussion draft In vitro diagnostic regulatory reform.
Client expense: $910,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Council on Environmental Quality (CEQ), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Natl Economic Council (NEC), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2018 · third_quarter · Medicare/Medicaid
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015. H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, respecting Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, and protecting communities. Draft legislation on establishment of Medicaid payment for patient navigation.
Client expense: $1,230,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
2018 · third_quarter · Medicare/Medicaid
Concerns with upper payment limit contained in H.R. 6- 21st Century Cures Act, 114th Congress, and the accelerated implementation date. Also working on a clear definition of what is included under 21st Century Cures Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Health Issues
Concerns with upper payment limits contained in H.R. 6- 21st Century Cures Act, 114th Congress, and the accelerated implementation date. Also working on clear definition of what items are covered by the 21st century Cures Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Medicare/Medicaid
- Home Infusion technical change to H.R.6 21st Century Cures to move wrap around training and monitoring services benefit forward from 2021 to 2018 implementation. - Medicare coverage and reimbursement - Medicare Part B drug payment model demonstration - HR 4724: Medicare IVIG Access Enhancement Act - Medicare Part D
Client expense: $250,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Health Issues
H.R. 5776 MOST Act. H.R. 6 21st Century CURES Act. Proposals to advance policies related to effective pain management. Issues related to medical device cybersecurity.
Client expense: $700,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
2018 · third_quarter · Pharmacy
Laboratory developed tests 21st Century Cures HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (RMI) This bill amends the Public Health Service Act to reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan, early stage investigators, and highrisk, highreward research. The NIH may require scientific data to be shared if the research is fully funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for 21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to these drugs
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Medicare/Medicaid
Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration; H.R. 750 - Ensuring Access to Quality Complex Rehabilitation Technology Act; H.R. 1361/S. 486/H.R. 3730 - To amend title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative wheelchairs and accessories (Protecting Beneficiary Access to Complex Rehab Technology Act of 2017); Issues related to reimbursement cuts in noncompetitive bidding areas, all provisions; 21st Century Cures Act (H.R. 6/H.R. 34 in the 114th Congress), competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2445 - the DMEPOS Access and Transparency Act of 2017 (DATA Act), all provisions; H.R. 4229 - Protecting HOME Access Act of 2017, all provisions; H.R. 2550 - Medicare Telehealth Parity Act of 2017, all provisions; H.R. 1625 - Consolidated Appropriations Act of 2018; issues pertaining to the Interim Final Rule (IFR) regarding non CB Area Relief for DME Items; Expanding and making permanent the Medicare power mobility device demonstration program; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act, all provisions (S. 2368 in the 114th Congress) ; DME issues in the FY2019 President's Budget and ESRD/DEMPOS proposed rule.
Client expense: Not reported · Firm income: $45,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
2018 · third_quarter · Medicare/Medicaid
Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration; H.R. 750 - Ensuring Access to Quality Complex Rehabilitation Technology Act; H.R. 1361/S. 486/H.R. 3730 - To amend title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative wheelchairs and accessories (Protecting Beneficiary Access to Complex Rehab Technology Act of 2017); Issues related to reimbursement cuts in noncompetitive bidding areas, all provisions; 21st Century Cures Act (H.R. 6/H.R. 34 in the 114th Congress), competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2445 - the DMEPOS Access and Transparency Act of 2017 (DATA Act), all provisions; H.R. 4229 - Protecting HOME Access Act of 2017, all provisions; H.R. 2550 - Medicare Telehealth Parity Act of 2017, all provisions; H.R. 1625 - Consolidated Appropriations Act of 2018; issues pertaining to the Interim Final Rule (IFR) regarding non CB Area Relief for DME Items; Expanding and making permanent the Medicare power mobility device demonstration program; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act, all provisions (S. 2368 in the 114th Congress); DME issues in the FY2019 President's Budget and ESRD/DEMPOS proposed rule.
Client expense: $150,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2018 · second_quarter · Computer Industry
Legislative & Regulatory Issues Related to Technology Policy, including R&D, Cybersecurity, Privacy, Health IT & Technology Procurement: Emerging technologies: Blockchain Technology, cloud, AI, IOT, Quantum Computing; S. 2217, the FUTURE of Artificial Intelligence Act of 2017; S. 760 Open, Public, Electronic, and Necessary Government Data Act; H.R. 6227, National Quantum Initiative Act. Implementation of H.R. 6, 21st Century Cures Act; S. 1693 Stop Enabling Sex Traffickers Act of 2017; H.R. 1865 Allow States and Victims to Fight Online Sex Trafficking Act of 2017. HR5674/S.2372 - VA Mission Act. Draft Data Acquisition and Technology Accountability and Security Act; S. 1989 Honest Ads Act, S.2382/H.R. 4943 Clarifying Use of Data (CLOUD) Act; cybersecurity vulnerability disclosure policy. S. 1691 Internet of Things Cybersecurity Improvement Act of 2017; data privacy; data breach, data security.
Client expense: $1,590,000 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Employment & Training Administration, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Immigration & Customs Enforcement (ICE), U.S. Trade Representative (USTR), White House Office
2018 · second_quarter · Medicare/Medicaid
- Home Infusion technical change to H.R.6 21st Century Cures to move wrap around training and monitoring services benefit forward from 2021 to 2018 implementation. - Medicare coverage and reimbursement - Medicare Part B drug payment model demonstration - HR 4724: Medicare IVIG Access Enhancement Act - Medicare Part D
Client expense: $540,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
H.R. 2646, the Helping Families in Mental Health Crisis Act; H.R. 2690, Strengthening Mental Health In Our Communities Act; H.R. 6, 21st Century Cures initiative; S. 481, Improving Regulatory Transparency for New Medical Therapies Act
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Computer Industry
Legislative & Regulatory Issues Related to Technology Policy, including R&D, Cybersecurity, Privacy, Health IT & Technology Procurement: Emerging technologies: Blockchain Technology, cloud, AI, IOT, Quantum Computing; S. 2217, the FUTURE of Artificial Intelligence Act of 2017; S. 760 Open, Public, Electronic, and Necessary Government Data Act; H.R. 6227, National Quantum Initiative Act. Implementation of H.R. 6, 21st Century Cures Act; S. 1693 Stop Enabling Sex Traffickers Act of 2017; H.R. 1865 Allow States and Victims to Fight Online Sex Trafficking Act of 2017. HR5674/S.2372 - VA Mission Act. Draft Data Acquisition and Technology Accountability and Security Act; S. 1989 Honest Ads Act, S.2382/H.R. 4943 Clarifying Use of Data (CLOUD) Act; cybersecurity vulnerability disclosure policy. S. 1691 Internet of Things Cybersecurity Improvement Act of 2017; data privacy; data breach, data security.
Client expense: $1,590,000 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Employment & Training Administration, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Immigration & Customs Enforcement (ICE), U.S. Trade Representative (USTR), White House Office
2018 · second_quarter · Medicare/Medicaid
- Home Infusion technical change to H.R.6 21st Century Cures to move wrap around training and monitoring services benefit forward from 2021 to 2018 implementation. - Medicare coverage and reimbursement - Medicare Part B drug payment model demonstration - HR 4724: Medicare IVIG Access Enhancement Act - Medicare Part D
Client expense: $540,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
FDA report on regulation of non-manufacturer medical device service; H.R.307, Pandemic and All-Hazards Preparedness Act Reauthorization - stockpile and diagnostic products; Opioid Crisis Response Act of 2018, Discussion Draft - opioid testing and treatment; H.R.6, 21st Century Cures Act - Clinical Laboratory Improvement Act - waiver guidance implementation, regulation of point of care diagnostics products; Diagnostic Accuracy and Innovation Act (Bucshon-DeGette) Discussion draft In vitro diagnostic regulatory reform.
Client expense: $900,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Council on Environmental Quality (CEQ), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Natl Economic Council (NEC), Office of Science & Technology Policy (OSTP), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2018 · second_quarter · Health Issues
Medicare provisions of Public Law 111-148 - Patient Protection and Affordable Care Act; Drug Shortage provisions (Title X) of Public Law 112-144 - Food and Drug Administration Safety and Innovation Act; H.R.6 - "21st Century Cures Act"; Appropriations for National Institutes of Health Senate HELP Committee Innovations legislation; Cancer "Moonshot" Appropriations
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2018 · second_quarter · Medicare/Medicaid
Concerns with upper payment limit contained in H.R. 6- 21st Century Cures Act, 114th Congress, and the accelerated implementation date. Also working on a clear definition of what is included under 21st Century Cures Act.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
Concerns with upper payment limits contained in H.R. 6- 21st Century Cures Act, 114th Congress, and the accelerated implementation date. Also working on clear definition of what items are covered by the 21st century Cures Act.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Medicare/Medicaid
Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration; H.R. 750 - Ensuring Access to Quality Complex Rehabilitation Technology Act; H.R. 1361/S. 486/H.R. 3730 - To amend title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative wheelchairs and accessories (Protecting Beneficiary Access to Complex Rehab Technology Act of 2017); Issues related to reimbursement cuts in noncompetitive bidding areas, all provisions; 21st Century Cures Act (H.R. 6/H.R. 34 in the 114th Congress), competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2445 - the DMEPOS Access and Transparency Act of 2017 (DATA Act), all provisions; H.R. 4229 - Protecting HOME Access Act of 2017, all provisions; H.R. 2550 - Medicare Telehealth Parity Act of 2017, all provisions; H.R. 1625 - Consolidated Appropriations Act of 2018; issues pertaining to the Interim Final Rule (IFR) regarding non CB Area Relief for DME Items; Expanding and making permanent the Medicare power mobility device demonstration program; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act, all provisions (S. 2368 in the 114th Congress); DME issues in the FY2019 President's Budget and ESRD/DEMPOS proposed rule.
Client expense: $170,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE